International Journal of Immunogenetics

Cover image for Vol. 41 Issue 4

Edited By: P.J. Travers

Impact Factor: 1.338

ISI Journal Citation Reports © Ranking: 2013: 126/144 (Immunology); 138/164 (Genetics & Heredity)

Online ISSN: 1744-313X



Author Guidelines


Manuscript Submission

International Journal of Immunogenetics accepts manuscripts electronically. To submit online, please go to http://mc.manuscriptcentral.com/ijig. Complete instructions for submitting manuscripts online are provided on the submission site. Help is available from the Editorial Office (iji@wiley.com).

Each article should be accompanied by a covering letter, signed by the main author, which states the following: 'The manuscript has been seen and approved by all authors, it is not under active consideration for publication, has not been accepted for publication, nor has it been published, in full or in part (except in abstract form)'. It should be noted that review of articles cannot proceed until the signed statement is received.

 

Copyright

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

 


Artwork

Please submit your artwork in electronic form. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript Format (EPS), and bitmap files (e.g. half-tones) in Tagged Image File Format (TIFF). Ideally, vector graphics that have been saved in metafile (WMF) or pict (PCT) format should be embedded within the body of the text file. Detailed information on our digital illustration standards is available at: http://authorservices.wiley.com/bauthor/illustration.asp
Avoid using tints if possible; if they are essential to the understanding of the figure, try to make them coarse.
In the full-text online edition of the journal, figure legends may be truncated in abbreviated links to the full screen version. Therefore, the first 100 characters of any legend should inform the reader of key aspects of the figure.

 

Colour Illustrations

It is the policy of International Journal of Immunogenetics for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Wiley Blackwell requires you to complete and return a colour work agreement form before your paper can be published. If you are unable to download the form, please contact the editorial office at the above address and they will be happy to email or fax a form to you. Once completed, please return the form to:

Customer Services (OPI)
John Wiley & Sons Ltd, European Distribution Centre
New Era Estate
Oldlands Way
Bognor Regis
West Sussex
PO22 9NQ


Scanned or faxed copies will not be accepted. Please note that any article received by Wiley Blackwell with colour work will not be published until a completed colour work agreement form has been received.

 

Page Proofs

The corresponding author will receive an e-mail alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. Proofs can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Proofs will be posted if no e-mail address is available; in your absence, please arrange for a colleague to access your e-mail to retrieve the proofs.

 

Offprints

The corresponding author will receive a pdf 'reprint' of his or her article. Additional offprints can be ordered via http://offprint.cosprinters.com/.

 

Types of Paper

(1) Full length papers (original articles).
(2) Short communications: these should not exceed four pages when printed.
(3) Review articles and invited commentaries (on selected reviews) on circumscribed fields of immunogenetics.
(4) Letters to the Editor or Reviews Editor
In addition, announcements of scientific societies. which are of interest to the immunogeneticist, can be published.

 

Full-length Papers

These should follow the pattern given below. Deviations are acceptable if required by the contents of the communication.
(1) Title of the paper.
(2) Name(s) and e-mail address(es) of the author(s).
(3) Full affiliation(s) of the author(s).
(4) Address for proofs and reprints: this address will be printed as a footnote on the first page of the final print.
(5) Summary, not exceeding 300 words. (1-5 on a separate sheet.)
(6) The article: Introduction, Materials and Methods, Results and Discussion (separate or together).
(7) Acknowledgements.
(8) References given as e.g.
Smith (1971), Smith & Smith (1972) or Smith et al. (1973) in the text, and the References list should follow alphabetical order, e.g.
Abel, J.D. & McMahon, P. (1972) New aspects of the development of the C6 component of complement. Immunology, 12, 234.
Ivanyi, P. & De Greeve, P. (1978) Individual mice of one inbred strain produce anti-H-2 and anti-HLA antibodies of different specificities. In: Origin of Inbred Mice (ed. by H. C. Morse) p.633. Academic Press, New York.
Race, R.R. & Sanger, R. (1968) Blood Group in Man, 5th edn, p.599. Blackwell, Oxford.
For references with more than 10 authors, list the first 6 then et al and journal titles should be listed in full.

 

Short Communications

These are understood to be preliminary reports, but must still be based on sufficient supporting evidence. They should not exceed four pages when printed including any figures and tables. The scheme suggested is as follows.
(1) Title.
(2) Name(s) of the author(s).
(3) Full affiliation(s) of the author(s).
(4) Address for reprints. (1-4 on a separate sheet.)
(5) Summary, not exceeding 50 words.
(6) The article, with or without subtitles.
(7) Acknowledgements.
(8) References.

 

Review Articles and Invited Commentaries

Reviews are typically invited by the Reviews Editor, and Commentaries upon selected reviews will also be invited when appropriate. Authors planning to write review articles for International Journal of Immunogenetics are asked to contact the Reviews Editor (Derek Middleton: Derek.Middleton@rlbuht.nhs.uk) first.

 

Letters to the Editor/Reviews Editor

We are keen to engage in dialogue with our readers and welcome Letters to the Editor/Reviews Editor in response to any of our research articles or reviews. Please make it clear which article you are responding to and give your full contact details.

 

Ethical Policy

International Journal of Immunogenetics is a member of the UK Committee on Publication Ethics and subscribes to its recommendations (Committee on Publication Ethics (COPE): guidelines on good publication practice. BJU International (2000), 85, 2-7). When reporting research on human subjects, the work must comply with the principles of the Declaration of Helsinki (1964) (British Medical Journal, 1964, ii, 177). Consequently, authors should indicate that ethical approval of the study was granted, and, where appropriate, that informed consent was given. Experiments using human tissue must be shown to comply with national and local ethical guidelines. Experiments using animal models must also be shown to comply with national guidelines and legislation.

The Editors reserve the right to reject a paper on ethical grounds.

 

Conflict of Interest

Authors are expected to disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work, and institutional or corporate affiliations of the authors, should be acknowledged on the title page. Articles are considered for publication on the understanding that neither the article nor its essential substance has been or will be published elsewhere before appearing in International Journal Immunogenetics. Abstracts and press reports published in connection with scientific meetings are not considered as publications.

 

Early View

International Journal of Immunogenetics is covered by Wiley Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles mean that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Indentifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continued to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html 

 

Author Services

NEW: Online production tracking is now available for articles through Wiley's Author Services.
Author Services enables authors to track their article - once it has been accepted – through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they do not need to contact the Production Editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Authors are encouraged to visit the Wiley Blackwell website for authors which details further information on the preparation and submission of articles and figures and gives access to the Wiley Blackwell house style guide: http://authorservices.wiley.com/bauthor/journal.asp

 

Author Material Archive Policy

Please note that unless specifically requested, Wiley

Blackwell will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.

 

Disclaimer

The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal, the views and opinions expressed do not necessarily reflect those of the Publisher and the Editors, neither does the publication of advertisements constitute any endorsement by the Publisher and Editors of the products advertised.

SEARCH

SEARCH BY CITATION